Pharmacies under attack: Ramsay Health Care Limited wants in

Pharmaceuticals: Potentially coming to a supermarket or hospital near you

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For years now, supermarket giants Woolworths Limited (ASX: WOW) and Coles – owned by Wesfarmers Limited (ASX: WES) have pushed to have rules around retail chemists relaxed.

They may have just found a new ally, with reports that hospital operator, Ramsay Health Care Limited (ASX: RHC), has backed draft recommendations to open up the pharmacy industry to other retailers.

A competition policy review led by Professor Ian Harper, has recommended removing long-standing ownership and location rules for pharmacies. One of which is that only a registered pharmacist is allowed to own a retail pharmacy, a law that has been in place for 80 years. There are also rules prohibiting new pharmacies from being established within 1.5kms of an existing one.

So far those rules have locked out retailers like Coles and Woolies from entering the pharmacy business.

But the protagonists face a powerful adversary in the Pharmacy Guild of Australia, as well as large corporations such as Sigma Pharmaceuticals Limited (ASX: SIP) and Australian Pharmaceutical Industries Ltd (ASX: API), which own, operate or supply pharmacies.

Ramsay already operates in-hospital pharmacies in 39 of its 69 Australian hospitals but is clearly keen to run more retail pharmacies. In a submission to the Harper review, Ramsay says non-pharmacists should be able to own pharmacies, in much the same way as non-doctors are allowed to own medical or pathology centres.

Pharmacies are already under pressure from the discounters such as Chemists Warehouse and Good Price Pharmacy Warehouse. Sigma has been fighting back though, acquiring Discount Drug Stores and its 121 discount pharmacies in September 2014. API, on the other hand, is rolling out its Priceline (don't dispense medicine) and Priceline Pharmacy stores to compete.

The problem for all pharmacy owners is that if current rules are relaxed, consumers may well be able to buy their pharmaceutical products in their local supermarkets. That could have a similar effect on pharmacies located near supermarkets as it has had on independent fruit stores, butchers and bakers. We'll have to wait for the final report in March to find out.

Motley Fool writer/analyst Mike King owns shares in Woolworths. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »